TITLE

SWOT Analysis

PUB. DATE
August 2007
SOURCE
Shire Pharmaceuticals Group, PLC SWOT Analysis;Aug2007, p5
SOURCE TYPE
SWOT Analysis
DOC. TYPE
SWOT Analysis
ABSTRACT
A business analysis of Shire Pharmaceuticals Group PLC, a global specialty pharmaceutical company, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include product portfolio. Weaknesses include increasing SG&A expenses. Opportunities for improvement include acquisition of New River. Threats to the company include patent infringement.
ACCESSION #
26859942

 

Related Articles

  • Key Facts.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;Mar2008, p4 

    Key facts about Shire Pharmaceuticals Group PLC, a company that develops and markets pharmaceutical products, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and number of employees. SIC and NAICS codes are also supplied.

  • Shire Pharmaceuticals Group, PLC SWOT Analysis.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;August 2003, p1 

    Presents an overview of Shire Pharmaceuticals Group PLC, a pharmaceutical company which focuses on four therapeutic areas, namely central nervous system disorders, gastrointestinal, oncology and anti-infectives. Company overview, including revenues generated in fiscal year 2002 and location of...

  • Key Facts.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;August 2003, p4 

    Presents key facts about Shire Pharmaceuticals Group PLC, a pharmaceutical company which focuses on four therapeutic areas, namely central nervous system disorders, gastrointestinal, oncology and anti-infectives. Address and contact information; Revenues and financial year end data; Number of...

  • SWOT Analysis.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;August 2003, p5 

    Provides a business analysis of Shire Pharmaceuticals Group PLC, a pharmaceutical company which focuses on four therapeutic areas, namely central nervous system disorders, gastrointestinal, oncology and anti-infectives, focusing on its strengths, weaknesses, opportunities for improvement and...

  • Shire Pharmaceuticals Group, PLC SWOT Analysis.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;April 2004, p1 

    Presents an overview of Shire Pharmaceuticals Group PLC, a company which is a rapidly growing international emerging pharmaceutical company with a strategic focus on four therapeutic areas-central nervous system disorders, gastrointestinal, oncology and anti-infectives. Company overview,...

  • Company Overview.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;April 2004, p4 

    Presents an overview Shire Pharmaceuticals Group PLC, a company which is a rapidly growing international emerging pharmaceutical company with a strategic focus on four therapeutic areas-central nervous system disorders, gastrointestinal, oncology and anti-infectives. Revenues generated in fiscal...

  • SWOT Analysis.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;April 2004, p5 

    Provides a business analysis of Shire Pharmaceuticals Group PLC, a company which is a rapidly growing international emerging pharmaceutical company with a strategic focus on four therapeutic areas-central nervous system disorders, gastrointestinal, oncology and anti-infectives, focusing on its...

  • Shire Pharmaceuticals Group, PLC SWOT Analysis.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;Sep2005, p1 

    Presents an overview of Shire Pharmaceuticals Group PLC, a global specialty pharmaceutical company with a strategic focus on developing and marketing products in the areas of central nervous system, gastrointestinal and renal diseases. Company overview, including revenues generated in fiscal...

  • Company Overview.  // Shire Pharmaceuticals Group, PLC SWOT Analysis;Sep2005, p4 

    Presents an overview of Shire Pharmaceuticals Group PLC, a global specialty pharmaceutical company. Revenues generated in fiscal year ended December 2004; Principal business offered, including developing and marketing products in the areas of central nervous system, gastrointestinal and renal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics